ETRA

Electra Therapeutics, Inc.

NasdaqHealthcareBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Insider activity for last month from Oct 16 to Nov 16.

How these metrics are calculated

Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.

Total buying$8.70M32 buys
Total selling$00 sales
Net open-market+$8.70MBuying minus selling
Active insiders4Distinct reporting owners

ETRA transaction history

Newest filings · 20 transactions per page

Latest insider transactions

Form 4 filings from last month.
Newest company filings
InsiderActivityDisclosed valueFiled (ET)
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$16.9kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$175kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$132kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$33.0kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$311kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$77.1kView disclosure →
ORBIMED ADVISORS LLC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$16.9kView disclosure →
ORBIMED ADVISORS LLC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$175kView disclosure →
ORBIMED ADVISORS LLC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$132kView disclosure →
ORBIMED ADVISORS LLC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$33.0kView disclosure →
ORBIMED ADVISORS LLC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$311kView disclosure →
ORBIMED ADVISORS LLC
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$77.1kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+3
Large buy

A buy above $1.0M, or above twice the company’s median insider trade with at least three prior trades in the sample.

Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$915kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$226kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$141kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$35.4kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$289kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$72.1kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$777kView disclosure →
Gordon Carl L
Director
DIR
Buy
Form 4 code P. Open-market or private purchase of a non-derivative or derivative security.
Cluster buy
At least two distinct reporting owners bought within 14 days, with combined known value of at least $100k.
10% owner buy
The buyer is a beneficial owner of more than 10% of the company.
+2
Director buy

The buyer is identified as a director.

Repeat buyer

The same owner reported more than one buy within 30 days.

SEC filing ↗
$192kView disclosure →

Insider activity report

Calendar-month buckets within the selected date range

Latest filing: Nov 10, 2026

Open-market transaction mix · 32 transactions in the selected period
32 buys100%·0%0 sells

Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.

View exact monthly counts and disclosed values
Monthly activity within the selected period; unknown values remain unknown.
MonthBuysSellsAwards (A)Buy valueSell valueNet P/S value
Oct 2026000$0$0$0
Nov 20263200$8,699,293.98$0+$8,699,293.98

Distinct insiders active

Reporting-owner CIKs by month · peak Nov 2026 (4)
Oct 2026: 0 insidersNov 2026: 4 insiders
Oct 2026Nov 2026
4distinct insiders in selected period
Largest insider activity
By absolute net disclosed value · current transaction page
2 insiders
Filing, role and holdings details

Filing-only signals

Deterministic matches in the selected period

Recent filing activity
Most recent 6 transactions on this page · color = transaction code

Filing detail checks

Secondary metrics for the selected period
Largest buy$915k
Largest sale—
10b5-1 detected0
Amended rows0

Transaction codes

By Form 4 transaction code in selected period
32transactionstxns
  • P · Open-market buys · dominant32 · 100%

Activity by reported role

A joint filing can contribute to multiple roles
Director32

Reported Holdings After

Separated by insider, security, and ownership type

ORBIMED ADVISORS LLCCommon Stock · Indirect · See footnotes
5.26M1.86MNov 3, 2026Nov 10, 2026
2,194,579Nov 10, 2026
OrbiMed Genesis GP LLCCommon Stock · Indirect · See footnotes
5.26M1.86MNov 3, 2026Nov 10, 2026
2,194,579Nov 10, 2026
Gordon Carl LCommon Stock · Indirect · See footnotes
5.26M1.86MNov 3, 2026Nov 10, 2026
2,194,579Nov 10, 2026

These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.

Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells red
2 active days
Oct 16 → Nov 16
LessMore

Electra Therapeutics, Inc. Insider Activity FAQ

SEC Form 4 context

Who recently reported transactions at Electra Therapeutics, Inc.?

GORDON CARL L, ORBIMED ADVISORS LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC.

When was the latest reported open-market purchase?

Gordon Carl L reported a buy on Nov 10, 2026 valued at $16.9k. Read the SEC filing.

When was the latest reported open-market sale?

No code-S sale is available for this period.

What is the recent purchase and sale balance?

Net open-market buying in the selected period was $8,699,293.98.

Where can I see the original SEC filing?

Every transaction row and latest-activity fact links to its original SEC filing.

What do these Form 4 transaction codes mean?

P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.